Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Yohei, Ikeno"'
Autor:
Hiroyasu, Sakai, Yujie, Zhou, Yu, Miyauchi, Yuta, Suzuki, Yohei, Ikeno, Risako, Kon, Nobutomo, Ikarashi, Yoshihiko, Chiba, Tomoo, Hosoe, Junzo, Kamei
Publikováno v:
Biological and Pharmaceutical Bulletin. 45:910-918
Cisplatin is a chemotherapy drug used to treat a variety of cancers. Muscle loss in cancer patients is associated with increased cancer-related mortality. Previously, we suggested that cisplatin administration increases the atrophic gene expressions
Autor:
Yohei Ikeno, Maya Inomata, Yuka Tsukimura, Yuta Suzuki, Hiroto Takeuchi, Yui Harada, Risako Kon, Nobutomo Ikarashi, Yoshihiko Chiba, Takeshi Yamada, Junzo Kamei, Hiroyasu Sakai
Publikováno v:
The Journal of nutritional biochemistry. 103
Previously it was shown that cisplatin causes muscle atrophy. Under this condition, cisplatin increased the expression of atorogenes, such as muscle ring finger 1 and atrogin-1 (also known as muscle atrophy F-box protein), in mouse skeletal muscle. I
Autor:
Yuka Tsukimura, Takeshi Yamada, Hiroyasu Sakai, Yuta Suzuki, Risako Kon, Maya Inomata, Yoshihiko Chiba, Junzo Kamei, Nobutomo Ikarashi, Yohei Ikeno
Publikováno v:
Toxicology and applied pharmacology. 403
We previously demonstrated that cisplatin administration in mice induces muscle atrophy and an increase in the expression of two muscle-specific ubiquitin E3 ligase genes, muscle ring finger protein 1 (MuRF1), and atrophy gene-1 (atrogin-1), in skele
Publikováno v:
International Journal of Pharmaceutics. 381:49-55
The purpose of our study was to investigate the potential of cell-penetrating peptides; penetratin as novel delivery vector, on the systemic absorption of therapeutic peptides and proteins across different mucosal administration sites. The absorption
Autor:
Yohei, Ikeno, Daisuke, Arii, Hirofumi, Nakajima, Kunihiko, Murooka, Michio, Nojima, Akio, Kidokoro
Publikováno v:
Gan to kagaku ryoho. Cancerchemotherapy. 41(5)
The closed-system transfer device (CSTD), which is used to prevent the exposure of medical staff to anticancer drugs, has been reported to allow safe preparation and administration of these drugs to patients. At many medical institutions, however, th
Publikováno v:
Gan to kagaku ryoho. Cancerchemotherapy. 39(13)
Docetaxel hydrate(DTX), a taxane anticancer drug, is known to be effective against a wide range of cancers, including breast cancer and non-small cell lung cancer. The DTX preparation Taxotere(2-vial DTX)has conventionally required dissolution in the
Publikováno v:
Gan to kagaku ryoho. Cancerchemotherapy. 39(4)
Oxaliplatin (L-OHP), a platinum-containing antineoplastic agent, is a key drug for the treatment of colorectal cancer. However, it is often difficult to continue with its treatment because of the expression of allergic reactions. This study was an in